Clinical Trial Update: Atomoxetine and DAW2022 on OSA Severity [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update plans to assess the effects of atomoxetine and the DAW2022 compound on obstructive sleep apnea severity, with recruiting statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Atomoxetine (Atomoxetine)
• DAW2022

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea | Phase 1, Phase 2 | Status: RECRUITING